Show Summary Details
Page of

Hallucinogens and Dissociatives 

Hallucinogens and Dissociatives
Hallucinogens and Dissociatives

Darius A. Rastegar

and Michael I. Fingerhood

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 09 April 2020

Hallucinogens, also known as psychedelics, are a broad range of agents that alter perception in different ways. These include phenylethylamines (e.g., ecstasy), ergot alkaloids (e.g., lysergic acid diethylamide, or LSD), tryptamines (e.g., psilocybin), anticholinergics (e.g., jimsonweed), and terpenoids (e.g., salvinorin). Dissociative anesthetics—including phencyclidine (PCP) and ketamine—are a related class of drugs that share many characteristics. Hallucinogen use is highest among young adults; MDMA is the most commonly used agent, followed by LSD and PCP. There appear to be few serious lasting complications associated with hallucinogen use. There are few data on treatment of individuals who use hallucinogens or dissociatives.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.